Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uros Markovic

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|July 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster DoseUros Markovic, Elvira Scalisi, Giuliana Giunta, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Annals of Hematology|May 9, 2026
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphomaSalvatore Perrone, Riccardo Tomasello, Simona Raso, et al.
Annals of Hematology|March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter studySalvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
European Journal of Haematology|September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significanceGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Journal of Clinical Medicine|June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma NetworkConcetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
Annals of Hematology|April 12, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life studySalvatore Leotta, Uros Markovic, Andrea Duminuco, et al.
British Journal of Haematology|February 9, 2022
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL studyElena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, et al.
Cancers|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) ProjectElisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
European Journal of Haematology|July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET surveyBruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|July 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster DoseUros Markovic, Elvira Scalisi, Giuliana Giunta, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Annals of Hematology|May 9, 2026
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphomaSalvatore Perrone, Riccardo Tomasello, Simona Raso, et al.
Annals of Hematology|March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter studySalvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
European Journal of Haematology|September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significanceGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Journal of Clinical Medicine|June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma NetworkConcetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
Annals of Hematology|April 12, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life studySalvatore Leotta, Uros Markovic, Andrea Duminuco, et al.
British Journal of Haematology|February 9, 2022
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL studyElena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, et al.
Cancers|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) ProjectElisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
European Journal of Haematology|July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET surveyBruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
Pageof 5